Bristol-Myers Squibb Co. et al. Correct FDA Notice on Withdrawal of Drug Applications

Summary

The FDA is correcting a notice from June 8, 2011, regarding the withdrawal of approval for 70 new drug applications and 97 abbreviated new drug applications, which incorrectly listed an applicant for one of the applications, NDA 018380, as Bristol-Myers Squibb Co. instead of Hospira, Inc.